| PEB Quarterly Update - Cxbladder Test Volumes Steady in Q4 24 |
| 09/04/24 | PRICE SENSITIVE | 105.41KB | Share |
|
| PEB Pacific Edge Directors Give Notice of Retirement |
| 14/03/24 | PRICE SENSITIVE | 107.17KB | Share |
|
| PEB Quarterly Update - Test Volumes Fall Following Restructure |
| 22/01/24 | PRICE SENSITIVE | 105.63KB | Share |
|
| PEB Financial Results for the Half Year to 30 September 2023 |
| 23/11/23 | PRICE SENSITIVE | 130.65KB | Share |
|
| PEB Kaiser Permanente EMR Integration goes live |
| 15/11/23 | PRICE SENSITIVE | 109.53KB | Share |
|
| PEB Quarterly Update - Q2 24 Cxbladder Test Volumes Resilient |
| 11/10/23 | PRICE SENSITIVE | 369.14KB | Share |
|
| PEB FDA Signals Intent to Regulate Lab Developed Tests |
| 02/10/23 | PRICE SENSITIVE | 120.36KB | Share |
|
| PEB Novitas Releases New Draft LCD |
| 28/07/23 | PRICE SENSITIVE | 114.97KB | Share |
|
| PEB Quarterly Update - Q1 24 Test Volumes Reach New Heights |
| 18/07/23 | PRICE SENSITIVE | 141.34KB | Share |
|
| PEB Pacific Edge Welcomes Stay of Novitas LCD |
| 06/07/23 | PRICE SENSITIVE | 109.39KB | Share |
|
| PEB Pacific Edge Updates Billing Policies for US Testing |
| 03/07/23 | PRICE SENSITIVE | 306.08KB | Share |
|
| PEB Annual Report 2023 |
| 22/06/23 | PRICE SENSITIVE | 5.01MB | Share |
|
| PEB Medicare Coverage of Cxbladder Expected to Cease |
| 07/06/23 | PRICE SENSITIVE | 124.4KB | Share |
|
| PEB Pacific Edge Trading Halt |
| 06/06/23 | PRICE SENSITIVE | 109.31KB | Share |
|
| PEB Clarification of Novitas Timeline |
| 02/06/23 | PRICE SENSITIVE | 108.53KB | Share |
|
| PEB Pacific Edge Delivers on Growth Strategy in FY 2023 |
| 25/05/23 | PRICE SENSITIVE | 209.54KB | Share |
|
| PEB Quarterly Update - Q4 23 Test Volumes Reach New Record |
| 18/04/23 | PRICE SENSITIVE | 1.06MB | Share |
|
| PEB Quarterly Investor Update - Q3 FY23 Test Volumes rise 36% |
| 19/01/23 | PRICE SENSITIVE | 801.97KB | Share |
|
| PEB Te Whatu Ora - Southern Commercial Agreement Completed |
| 13/01/23 | PRICE SENSITIVE | 567.26KB | Share |
|
| PEB Enhanced Cxb Tests Deliver Improved Diagnostic Performance |
| 13/12/22 | PRICE SENSITIVE | 226.73KB | Share |
|
| PEB Financial Results for the Half Year to 30 September 2022 |
| 24/11/22 | PRICE SENSITIVE | 265.26KB | Share |
|
| PEB Quarterly Investor Update - Q2 FY23 Test Volumes rise 36% |
| 17/10/22 | PRICE SENSITIVE | 1.14MB | Share |
|
| PEB Update on Te Whatu Ora - Southern Commercial Agreement |
| 22/09/22 | PRICE SENSITIVE | 557.33KB | Share |
|
| PEB PACIFIC EDGE COMMENTS ON PROPOSED NOVITAS LCD |
| 01/08/22 | PRICE SENSITIVE | 673.56KB | Share |
|
| PEB Trading Halt Update: Novitas Proposes Changes to LCD |
| 29/07/22 | PRICE SENSITIVE | 260.17KB | Share |
|
| PEB Southern District Health Region Adopts Cxbladder Tests |
| 21/07/22 | PRICE SENSITIVE | 218.92KB | Share |
|
| PEB Pacific Edge Investor Update: Q1 FY23 Test Volumes Rise 32% |
| 20/07/22 | PRICE SENSITIVE | 1.16MB | Share |
|
| PEB Annual Report 2022 |
| 22/06/22 | PRICE SENSITIVE | 7.59MB | Share |
|
| PEB Kaiser Permanente agrees to Cxbladder EMR Integration |
| 01/06/22 | PRICE SENSITIVE | 200.51KB | Share |
|
| PEB Audited Financial Results for the year to 31 March 2022 |
| 26/05/22 | PRICE SENSITIVE | 675.83KB | Share |
|
| PEB Pacific Edge Appoints Tony Barclay to its Board |
| 17/03/22 | PRICE SENSITIVE | 201.51KB | Share |
|
| PEB PEB Announces Agreement with Northern Health in Australia |
| 09/12/21 | PRICE SENSITIVE | 196.65KB | Share |
|
| PEB Pacific Edge Results for Six Months Ended 30 September 2021 |
| 25/11/21 | PRICE SENSITIVE | 234.07KB | Share |
|
| PEB Interim Financial Results to be Announced 25 November 2021 |
| 03/11/21 | PRICE SENSITIVE | 191.73KB | Share |
|
| PEB Pacific Edge Appoints Dr Peter Meintjes as its new CEO |
| 29/10/21 | PRICE SENSITIVE | 217.61KB | Share |
|
| PEB Pacific Edge Opens Retail Offer for Existing Shareholders |
| 28/09/21 | PRICE SENSITIVE | 190.5KB | Share |
|
| PEB Pacific Edge Placement Upsized Following Strong Demand |
| 24/09/21 | PRICE SENSITIVE | 223.14KB | Share |
|
| PEB PE Dual Lists on ASX; Announces Capital Raise to Accelerate |
| 23/09/21 | PRICE SENSITIVE | 515.49KB | Share |
|
| PEB GENERAL: PEB: Response to Media Speculation - ASX Dual Listing |
| 09/09/21 | PRICE SENSITIVE | 186.68KB | Share |
|
| PEB GENERAL: PEB: Update on Dual Listing Process and Market Speculation |
| 08/09/21 | PRICE SENSITIVE | 191.57KB | Share |
|
| PEB GENERAL: PEB: AMENDED: Continued Growth Momentum into Q1 FY22 |
| 29/07/21 | PRICE SENSITIVE | 236.51KB | Share |
|
| PEB GENERAL: PEB: Pacific Edge Reports Continued Growth Momentum into Q1 FY22 |
| 29/07/21 | PRICE SENSITIVE | 236.5KB | Share |
|
| PEB GENERAL: PEB: Outperformance confirmed from combined use of Cxbladder |
| 08/07/21 | PRICE SENSITIVE | 259.89KB | Share |
|
| PEB ANNREP: PEB: Annual Report and Shareholder Letter 2021 |
| 30/06/21 | PRICE SENSITIVE | 3.02MB | Share |
|
| PEB GENERAL: PEB: Kaiser Permanente to Commence Use of Second Cxbladder Test |
| 21/06/21 | PRICE SENSITIVE | 196.64KB | Share |
|
| PEB FLLYR: PEB: PEB Financial Results for the 12 months to 31 March 2021 |
| 27/05/21 | PRICE SENSITIVE | 211.13KB | Share |
|
| PEB ADMIN: PEB: Pacific Edge Appoints Chief Operating Officer |
| 05/05/21 | PRICE SENSITIVE | 200.22KB | Share |
|
| PEB FLLYR: PEB: PEB Full Year Result to be Announced 27 May 2021 |
| 03/05/21 | PRICE SENSITIVE | 200.52KB | Share |
|
| PEB GENERAL: PEB: United Healthcare Issues Positive Coverage Cxbladder |
| 09/04/21 | PRICE SENSITIVE | 236.4KB | Share |
|
| PEB HALFYR: PEB: Pacific Edge Unaudited Financial Results to 30 Sept 2020 |
| 26/11/20 | PRICE SENSITIVE | 226.67KB | Share |
|
| PEB ADMIN: PEB: David Levison Appointed to US Exec Team to Drive US Growth |
| 19/11/20 | PRICE SENSITIVE | 164.41KB | Share |
|
| PEB GENERAL: PEB: Pacific Edge Joins S&P / NZX 50 Index |
| 14/10/20 | PRICE SENSITIVE | 208.67KB | Share |
|
| PEB GENERAL: PEB: PEB Attracts Growth Capital at Market Premium |
| 24/07/20 | PRICE SENSITIVE | 219.14KB | Share |
|
| PEB GENERAL: PEB: Pacific Edge Notified of Positive LCD Decision in USA |
| 03/07/20 | PRICE SENSITIVE | 207.25KB | Share |
|
| PEB ANNREP: PEB: Annual Report & Shareholder Letter |
| 26/06/20 | PRICE SENSITIVE | 8.32MB | Share |
|
| PEB GENERAL: PEB: Kaiser Permanente Approves Commercial Use of Cxbladder |
| 17/06/20 | PRICE SENSITIVE | 195.92KB | Share |
|
| PEB FLLYR: PEB: Pacific Edge Announces FY20 Results |
| 29/05/20 | PRICE SENSITIVE | 221.72KB | Share |
|
| PEB FLLYR: PEB: PEB Full Year Result to be Announced 29 May 2020 |
| 25/05/20 | PRICE SENSITIVE | 190.88KB | Share |
|
| PEB Public Healthcare Providers increase use of Cxbladder |
| 06/04/20 | PRICE SENSITIVE | 275.03KB | Share |
|
| PEB Completion of Placement |
| 22/11/19 | PRICE SENSITIVE | 148.11KB | Share |
|
| PEB Pacific Edge FY20 Interim Results and Capital Raising |
| 21/11/19 | PRICE SENSITIVE | 558.96KB | Share |
|
| PEB Annual Report & Shareholder Letter |
| 28/06/19 | PRICE SENSITIVE | 5.2MB | Share |
|
| PEB Pacific Edge Reports Continued Growth in FY19 |
| 29/05/19 | PRICE SENSITIVE | 168.63KB | Share |
|
| PEB PEB FY Result to be announced 29 May 2019 |
| 16/05/19 | PRICE SENSITIVE | 150.54KB | Share |
|
| PEB Cxbladder Adoption Roll-Out Advances in New Zealand |
| 18/03/19 | PRICE SENSITIVE | 150.33KB | Share |
|
| PEB Interim Report 2018 |
| 19/12/18 | PRICE SENSITIVE | 1.65MB | Share |
|
| PEB Share Purchase Plan Documents |
| 10/12/18 | PRICE SENSITIVE | 1.47MB | Share |
|
| PEB Cleansing Notice |
| 10/12/18 | PRICE SENSITIVE | 75.16KB | Share |
|
| PEB PE Completes $7 Million Placement of New Shares |
| 30/11/18 | PRICE SENSITIVE | 129.95KB | Share |
|
| PEB Cleansing Notice |
| 29/11/18 | PRICE SENSITIVE | 112.03KB | Share |
|
| PEB PE Announces Improved Result and Capital Raising |
| 29/11/18 | PRICE SENSITIVE | 177.17KB | Share |
|
| PEB Full Suite of Cxbladder Tests adopted by Capital &Coast DHB |
| 08/11/18 | PRICE SENSITIVE | 131.66KB | Share |
|
| PEB PE RECEIVES NOTIFICATION OF NATIONAL CMS REIMBURSEMENT RATE |
| 12/10/18 | PRICE SENSITIVE | 151.33KB | Share |
|
| PEB Pacific Edge 2018 Annual Meeting of Shareholders |
| 16/08/18 | PRICE SENSITIVE | 2.04MB | Share |
|
| PEB Another NZ Public Healthcare Providers Adopts Cxbladder |
| 16/08/18 | PRICE SENSITIVE | 131.86KB | Share |
|
| PEB Another NZ Public Healthcare Provider Signs Up to Cxbladder |
| 14/08/18 | PRICE SENSITIVE | 155.69KB | Share |
|
| PEB Notice of Change in Issued Capital Stock- Ordinary Shares |
| 30/07/18 | PRICE SENSITIVE | 248.68KB | Share |
|
| PEB PEB Attracts US Investment and Undertakes Share Placement |
| 30/07/18 | PRICE SENSITIVE | 143.87KB | Share |
|
| PEB Annual Report, Shareholder Letter & Section 209c Notice |
| 29/06/18 | PRICE SENSITIVE | 2.31MB | Share |
|
| PEB PEB Preliminary Results for Year Ended 31 March 2018 |
| 29/05/18 | PRICE SENSITIVE | 175.16KB | Share |
|
| PEB Pacific Edge Full Year Results to be Announced 29 May 2018 |
| 14/05/18 | PRICE SENSITIVE | 136.44KB | Share |
|
| PEB PACIFIC EDGE LIMITED INTERIM REPORT 2017 |
| 19/12/17 | PRICE SENSITIVE | 4.97MB | Share |
|
| PEB Interim Results - Half Year End 30 September 2017 |
| 29/11/17 | PRICE SENSITIVE | 212.02KB | Share |
|
| PEB Completion of shortfall bookbuild and $21.3m capital raise |
| 10/11/17 | PRICE SENSITIVE | 123.43KB | Share |
|
| PEB PEB Capital Raise Offer Documents |
| 18/10/17 | PRICE SENSITIVE | 42.24KB | Share |
|
| PEB PEB Rights Issue - Cleansing Notice |
| 18/10/17 | PRICE SENSITIVE | 120.68KB | Share |
|
| PEB Pacific Edge fully underwritten rights issue |
| 11/10/17 | PRICE SENSITIVE | 228.69KB | Share |
|
| PEB FY17 Cashflow Statement Reclassification |
| 27/09/17 | PRICE SENSITIVE | 318.76KB | Share |
|
| PEB Cxbladder Test Suite Adopted by MidCentral DHB |
| 03/08/17 | PRICE SENSITIVE | 138.89KB | Share |
|
| PEB Annual Report 2017, Annual Review & Section 209 Notice |
| 30/06/17 | PRICE SENSITIVE | 4.74MB | Share |
|
| PEB PEB FY17 Full Year Results - with full Audit Report |
| 24/05/17 | PRICE SENSITIVE | 167.26KB | Share |
|
| PEB Pacific Edge Undertakes $8m Share Placement |
| 15/02/17 | PRICE SENSITIVE | 143.58KB | Share |
|
| PEB Interim Results - Half Year End 30 September 2016 |
| 24/11/16 | PRICE SENSITIVE | 194.81KB | Share |
|
